Using an approach combining transcriptome analyses of miR-375 activation and inhibition as well as data exploration of the Cancer Cell Line Encyclopedia (CCLE) transcriptome database, we established SEC23A as a reliable miR-375 target, in accordance with previous reports in prostate carcinomas [33, 39]. The gene discussed is SEC23A; the disease is cancer.